JP2022523145A5 - - Google Patents

Info

Publication number
JP2022523145A5
JP2022523145A5 JP2021545857A JP2021545857A JP2022523145A5 JP 2022523145 A5 JP2022523145 A5 JP 2022523145A5 JP 2021545857 A JP2021545857 A JP 2021545857A JP 2021545857 A JP2021545857 A JP 2021545857A JP 2022523145 A5 JP2022523145 A5 JP 2022523145A5
Authority
JP
Japan
Prior art keywords
sequence
cdr
seq
chain
sequence described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021545857A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022523145A (ja
JP7492522B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/016949 external-priority patent/WO2020163564A2/en
Publication of JP2022523145A publication Critical patent/JP2022523145A/ja
Publication of JP2022523145A5 publication Critical patent/JP2022523145A5/ja
Priority to JP2024080881A priority Critical patent/JP7759996B2/ja
Application granted granted Critical
Publication of JP7492522B2 publication Critical patent/JP7492522B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021545857A 2019-02-06 2020-02-06 抗trem1抗体及び関連方法 Active JP7492522B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024080881A JP7759996B2 (ja) 2019-02-06 2024-05-17 抗trem1抗体及び関連方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962802161P 2019-02-06 2019-02-06
US62/802,161 2019-02-06
US201962889994P 2019-08-21 2019-08-21
US62/889,994 2019-08-21
PCT/US2020/016949 WO2020163564A2 (en) 2019-02-06 2020-02-06 Anti-trem1 antibodies and related methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024080881A Division JP7759996B2 (ja) 2019-02-06 2024-05-17 抗trem1抗体及び関連方法

Publications (3)

Publication Number Publication Date
JP2022523145A JP2022523145A (ja) 2022-04-21
JP2022523145A5 true JP2022523145A5 (cg-RX-API-DMAC7.html) 2023-02-01
JP7492522B2 JP7492522B2 (ja) 2024-05-29

Family

ID=71947128

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021545857A Active JP7492522B2 (ja) 2019-02-06 2020-02-06 抗trem1抗体及び関連方法
JP2024080881A Active JP7759996B2 (ja) 2019-02-06 2024-05-17 抗trem1抗体及び関連方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024080881A Active JP7759996B2 (ja) 2019-02-06 2024-05-17 抗trem1抗体及び関連方法

Country Status (20)

Country Link
US (3) US10836828B2 (cg-RX-API-DMAC7.html)
EP (1) EP3921344A4 (cg-RX-API-DMAC7.html)
JP (2) JP7492522B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210126638A (cg-RX-API-DMAC7.html)
CN (1) CN113748132B (cg-RX-API-DMAC7.html)
AU (1) AU2020218525A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021015479A2 (cg-RX-API-DMAC7.html)
CA (1) CA3128053A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021002075A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021010887A2 (cg-RX-API-DMAC7.html)
CR (1) CR20210462A (cg-RX-API-DMAC7.html)
DO (1) DOP2021000165A (cg-RX-API-DMAC7.html)
IL (1) IL284818A (cg-RX-API-DMAC7.html)
MX (1) MX2021009500A (cg-RX-API-DMAC7.html)
PE (1) PE20212269A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021551903A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202108570SA (cg-RX-API-DMAC7.html)
TW (1) TWI870382B (cg-RX-API-DMAC7.html)
WO (1) WO2020163564A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA202210284B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR125732A1 (es) * 2021-05-03 2023-08-09 UCB Biopharma SRL Anticuerpos anti-trem1
CN114807031A (zh) * 2022-05-13 2022-07-29 山东赛恩福干细胞工程集团有限公司 一种人外周血免疫细胞库和干细胞库的构建方法
KR20260017009A (ko) 2023-04-21 2026-02-04 셀시우스 테라퓨틱스, 인코포레이티드 항-trem1 항체 제제, 조성물 및 이의 용도
WO2025201129A1 (zh) * 2024-03-28 2025-10-02 北京丹序生物制药有限公司 一种抗触发受体-1抗体或其抗原结合片段及其应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787995B1 (en) 1992-01-28 2004-09-07 Fujitsu Limited Full color surface discharge type plasma display device
US20060084082A1 (en) 1997-03-07 2006-04-20 Human Genome Sciences, Inc. 186 human secreted proteins
CA2331386A1 (en) 1998-06-26 2000-01-06 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins
JP2002164544A (ja) 2000-11-28 2002-06-07 Sony Corp 半導体装置
WO2002058721A1 (en) 2000-12-08 2002-08-01 Baylor College Of Medicine Trem-1 splice variant for use in modifying immune responses
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
CA2342376C (en) 2001-03-20 2013-11-12 Marco Colonna A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
US8231878B2 (en) 2001-03-20 2012-07-31 Cosmo Research & Development S.P.A. Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
GB0122546D0 (en) 2001-09-19 2001-11-07 Univ Cranfield Optical fibre long period grating with thin film overlays
GB0401730D0 (en) 2004-01-27 2004-03-03 Bioxell Spa Diagnosis method
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
US8289572B2 (en) 2005-09-22 2012-10-16 Ricoh Production Print Solutions LLC Estimation of ink/toner coverage when printing
JP2007298739A (ja) 2006-04-28 2007-11-15 Toshiba Corp 組立て方法及び画像形成装置
RU2490223C2 (ru) 2006-11-21 2013-08-20 ГАРСИА Карлос Хавиер ФЕРНАНДЕЗ Способ предварительного смешивания и сухого заполнения волокном
JP5334995B2 (ja) 2008-01-16 2013-11-06 エヌエックスピー ビー ヴィ 相変化材料層を有する多層構造およびその製造方法
EP2268755A2 (en) 2008-03-14 2011-01-05 3M Innovative Properties Company Stretch releasable adhesive article
US8419721B2 (en) 2009-07-29 2013-04-16 Alcon Lensx, Inc. Optical system for ophthalmic surgical laser
US9493578B2 (en) 2009-09-02 2016-11-15 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
JP5470093B2 (ja) 2010-02-26 2014-04-16 株式会社ニフコ 保持装置
US20120317870A1 (en) 2011-06-20 2012-12-20 Gregory Allen Pratt Method and apparatus for use in the extermination of bed bug infestations
US9068575B2 (en) 2011-06-28 2015-06-30 Caterpillar Inc. Hydraulic control system having swing motor energy recovery
RS57827B1 (sr) 2012-02-15 2018-12-31 Novo Nordisk As Antitela koja vezuju protein 1 prepoznavanja peptidoglikana
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
JP6411218B2 (ja) 2012-02-15 2018-10-24 ノヴォ ノルディスク アー/エス 骨髄細胞で発現されるトリガー受容体1(trem−1)に結合し、それを遮断する抗体
US20150376294A1 (en) * 2012-12-03 2015-12-31 Rigshospitalet Anti-pad2 antibodies and treatment of autoimmune diseases
BR112015020862B1 (pt) 2013-02-28 2021-05-25 Hewlett-Packard Development Company, L.P. barra de impressão moldada
WO2014207910A1 (ja) 2013-06-28 2014-12-31 株式会社 東芝 テレビジョン装置、及びリモートコントローラ
FR3016679B1 (fr) 2014-01-22 2016-01-22 Air Liquide Robinet pour bouteille de fluide sous pression et bouteille correspondante
US9448150B2 (en) 2014-02-03 2016-09-20 Cameron International Corporation Method and apparatus for determining kinematic viscosity through the transmission and reception of ultrasonic energy
CN106536559B (zh) 2014-07-17 2021-04-27 诺和诺德股份有限公司 定点诱变trem-1抗体以降低黏度
EP3026061A1 (en) 2014-11-26 2016-06-01 Novo Nordisk A/S Site directed mutagenesis of trem-1 antibodies for decreasing viscosity.
US10615407B2 (en) 2014-08-14 2020-04-07 Battelle Memorial Institute Na—FeCl2 ZEBRA type battery
KR20240056629A (ko) 2014-09-28 2024-04-30 더 리전트 오브 더 유니버시티 오브 캘리포니아 자극성 및 비자극성 골수성 세포의 조절
AR103268A1 (es) * 2014-12-23 2017-04-26 Bristol Myers Squibb Co Anticuerpos contra tigit
IL254039B2 (en) * 2015-02-19 2023-12-01 Compugen Ltd Anti-pvrig antibodies and methods of use
WO2017058866A1 (en) * 2015-09-28 2017-04-06 Precision Immune, Inc. Anti-trem2 antibodies and uses thereof
EP3173438A1 (en) 2015-11-30 2017-05-31 SABIC Global Technologies B.V. Use of polypropylene composition for coffee cartridge
WO2017127933A1 (en) 2016-01-29 2017-08-03 The Governing Council Of The University Of Toronto Frizzled protein-binding agents and methods of use thereof
JP7023853B2 (ja) * 2016-03-04 2022-02-22 アレクトル エルエルシー 抗trem1抗体及びその使用方法
DE102016205647B4 (de) 2016-04-06 2018-11-29 Voith Patent Gmbh Ringgatter für eine hydraulische Maschine und Verfahren zum Schließen
PE20190115A1 (es) * 2016-04-15 2019-01-16 Immunext Inc Anticuerpos vista antihumanos y su uso
EP3263167B1 (en) 2016-06-30 2023-06-28 Wellspect AB Urinary catheter with varying properties
PL3609540T3 (pl) 2017-04-14 2023-03-27 Bolt Biotherapeutics, Inc. Sposób syntezy immunokoniugatu
EP3664845A4 (en) 2017-08-08 2021-03-10 Pionyr Immunotherapeutics, Inc. COMPOSITIONS AND METHODS OF DEACTIVATION OF MYELOID CELLS EXPRESSING TREM1

Similar Documents

Publication Publication Date Title
JP2021506244A5 (cg-RX-API-DMAC7.html)
TWI701259B (zh) 4﹘1bb抗體及其製備方法和應用
JP2023549555A5 (cg-RX-API-DMAC7.html)
JP2022514734A5 (cg-RX-API-DMAC7.html)
JP2020536543A5 (cg-RX-API-DMAC7.html)
JP7257971B2 (ja) 抗cd40抗体、その抗原結合フラグメント、およびその医学的使用
JP7649744B2 (ja) Btn3a結合タンパク質及びその使用
AU2018218753A1 (en) Anti-GPRC5D antibody and molecule containing same
TW201833141A (zh) 抗b7-h3抗體、其抗原結合片段及其醫藥用途
US20220242953A1 (en) Cd3 antibody and pharmaceutical use thereof
JP2019515646A (ja) Pd−l1に対する結合メンバー
JP2021514973A5 (cg-RX-API-DMAC7.html)
JP2021515806A (ja) 三重特異性抗原結合タンパク質
EP3625255A1 (en) Novel monoclonal antibodies to cytotoxic t-lymphocyte-associated protein 4 (ctla-4)
JP2018531219A (ja) Pd−l1抗体
JP2018531219A6 (ja) Pd−l1抗体
RS53072B (sr) Antitela za humani receptor programirane smrti pd-1
CN108948194B (zh) 一种新的ctla-4单克隆抗体
WO2022002033A1 (zh) 具有H2L2与HCAb结构的结合蛋白
CA3221866A1 (en) Antibodies and bispecific binding proteins that bind ox40 and/or pd-l1
JP2024523838A5 (cg-RX-API-DMAC7.html)
US12577314B2 (en) Anti-BCMA/anti-4-1BB bispecific antibodies and uses thereof
JP7652705B2 (ja) Btn2に対する特異性を有する抗体及びその使用
JP2025509702A (ja) GPC3陽性悪性細胞を標的殺傷するための二重特異性GPC3xCD28抗体およびGPC3xCD3抗体ならびにそれらの組み合わせ
WO2022002006A1 (zh) Fab-HCAb结构的结合蛋白